BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22143891)

  • 1. Readers' theatre: a communication tool for colorectal cancer screening.
    Cueva M; Dignan M; Kuhnley R
    J Cancer Educ; 2012 Jun; 27(2):281-6. PubMed ID: 22143891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readers' theatre as cancer education: an organic inquiry in Alaska awakening possibilities in a living spiral of understanding.
    Cueva M
    J Cancer Educ; 2010 Mar; 25(1):3-8. PubMed ID: 20094830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telenovela: an innovative colorectal cancer screening health messaging tool.
    Cueva M; Kuhnley R; Slatton J; Dignan M; Underwood E; Landis K
    Int J Circumpolar Health; 2013; 72():21301. PubMed ID: 23930245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a patient navigation program to promote colorectal cancer screening in rural Georgia, USA.
    Honeycutt S; Green R; Ballard D; Hermstad A; Brueder A; Haardörfer R; Yam J; Arriola KJ
    Cancer; 2013 Aug; 119(16):3059-66. PubMed ID: 23719894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy.
    Stock C; Knudsen AB; Lansdorp-Vogelaar I; Haug U; Brenner H
    Gastrointest Endosc; 2011 Mar; 73(3):435-443.e5. PubMed ID: 21353840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intervention to change the approach to colorectal cancer screening in primary care.
    Spruce LR; Sanford JT
    J Am Acad Nurse Pract; 2012 Apr; 24(4):167-74. PubMed ID: 22486831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliciting population preferences for mass colorectal cancer screening organization.
    Nayaradou M; Berchi C; Dejardin O; Launoy G
    Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of various strategies for colorectal cancer screening tests.
    Wohl P; Bednařík M; Wohl P; Cervenka M; Spičák J
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1157-64. PubMed ID: 21989120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
    Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
    Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods.
    Rozen P; Liphshitz I; Barchana M
    Eur J Cancer Prev; 2011 Jan; 20(1):46-53. PubMed ID: 21102339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(26):808-12. PubMed ID: 20613704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY; Chuah BY; Koh DC; Yeoh KG
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopy.
    Haug U; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):422-8. PubMed ID: 15734968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS; Lee HY; Jun JK; Shin A; Park EC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial factors associated with the adherence to a colorectal cancer screening program.
    Gili M; Roca M; Ferrer V; Obrador A; Cabeza E
    Cancer Detect Prev; 2006; 30(4):354-60. PubMed ID: 16963195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.